SLÁMA, Ondřej, Lukas POCHOP, Jiří ŠEDO, Jan ŠVANCARA, Petra ŠEDOVÁ, Lucie SVETLAKOVA, Regina DEMLOVÁ a Rostislav VYZULA. Effects of Early and Systematic Integration of Specialist Palliative Care in Patients with Advanced Cancer: Randomized Controlled Trial PALINT. JOURNAL OF PALLIATIVE MEDICINE. NEW ROCHELLE: MARY ANN LIEBERT, INC, 2020, roč. 23, č. 12, s. 1586-1593. ISSN 1096-6218. Dostupné z: https://dx.doi.org/10.1089/jpm.2019.0697.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Effects of Early and Systematic Integration of Specialist Palliative Care in Patients with Advanced Cancer: Randomized Controlled Trial PALINT
Autoři SLÁMA, Ondřej (203 Česká republika, garant, domácí), Lukas POCHOP (203 Česká republika), Jiří ŠEDO (203 Česká republika), Jan ŠVANCARA (203 Česká republika, domácí), Petra ŠEDOVÁ (203 Česká republika), Lucie SVETLAKOVA (203 Česká republika), Regina DEMLOVÁ (203 Česká republika, domácí) a Rostislav VYZULA (203 Česká republika, domácí).
Vydání JOURNAL OF PALLIATIVE MEDICINE, NEW ROCHELLE, MARY ANN LIEBERT, INC, 2020, 1096-6218.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30204 Oncology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.947
Kód RIV RIV/00216224:14110/20:00116202
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1089/jpm.2019.0697
UT WoS 000532181600001
Klíčová slova anglicky advanced cancer; early palliative care; hospital-specific palliative care issues; multidisciplinary care; specialist palliative care
Štítky 14110516, 14110811, 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 13. 5. 2021 07:48.
Anotace
Background: A broad consensus on the optimal structure, intensity, and timing of early specialist palliative care (SPC) intervention is lacking. Objective: To evaluate the benefit of an early and systematic palliative intervention alongside standard oncology care compared with standard oncology care alone in patients with advanced solid tumors. Design: PALINT, a single-center RCT, conducted at the Masaryk Memorial Cancer Institute, the largest comprehensive cancer center in the Czech Republic (CR). Setting/Subjects/Measurements: Patients with newly diagnosed advanced cancer within six weeks from the start of the palliative systemic therapy were randomly assigned to the integration of SPC (intervention; a consultation with a PC physician every six to eight weeks) or to the standard oncology care (control). The primary endpoint was the quality of life (QOL) assessed by EORTC QLQ C30 and Hospital Anxiety and Depression Scale (HADS) at three and six months. Results: From 2015 to 2017, a total of 126 patients were randomly assigned to intervention (60) or to control (66) arm. At baseline, at three and six months, the global QOL scores (mean, 95% CI) in the intervention and control arm were 58.6 (53.9-63.3), 61.9 (56.4-67.4) and 66.7 (60.2-73.2) versus 54.2 (49.4-58.9), 59.0 (53.7-64.3), and 62.8 (56.7-68.9), respectively. The prevalence of anxiety (HADS-A; value >7) was 36.7%, 27.5%, and 18.9% versus 34.8%, 23.5%, and 16.3% and the prevalence of depression (HADS-D; value >7) was 28.3%, 25.4%, and 29.7% versus 28.8%, 29.4%, and 27.9%, respectively. There was no significant difference between the two arms. The overall survival was similar in both arms (347 vs. 310 days; p = 0.203). Conclusions: A model of early integration of SPC consisting of a consultation with a PC physician alone every six to eight weeks did not increase the QOL of patients with advanced cancer compared with routine oncology care in a center with widely available supportive services. These negative results underline the importance of the multidisciplinary patient centered approach in the early SPC.
Návaznosti
LM2018128, projekt VaVNázev: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Akronym: CZECRIN)
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Český národní uzel Evropské sítě infrastruktur klinického výzkumu (CZECRIN)
VytisknoutZobrazeno: 13. 5. 2024 14:32